Hypertrophy of adenoids
ICD-10 J35.2 is a billable code used to indicate a diagnosis of hypertrophy of adenoids.
Hypertrophy of adenoids refers to the abnormal enlargement of the adenoid tissue, which is located in the nasopharynx, behind the nose and above the soft palate. This condition is commonly seen in children and can lead to various respiratory issues, including obstructive sleep apnea, chronic nasal obstruction, and recurrent otitis media due to Eustachian tube dysfunction. Clinically, patients may present with symptoms such as nasal congestion, mouth breathing, snoring, and difficulty sleeping. The disease progression can lead to complications like facial deformities and impaired speech development if left untreated. Diagnosis typically involves a thorough clinical evaluation, including a physical examination and, in some cases, imaging studies such as X-rays or endoscopy to assess the size of the adenoids and their impact on surrounding structures. Treatment options may include medical management with nasal corticosteroids or surgical intervention, such as adenoidectomy, especially in cases where significant airway obstruction or recurrent infections are present.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
J35.2 specifically covers hypertrophy of adenoids, which may lead to obstructive sleep apnea, chronic nasal obstruction, and recurrent ear infections. It is important to differentiate this condition from other respiratory disorders that may present with similar symptoms.
J35.2 should be used when the primary issue is the hypertrophy of adenoids causing respiratory symptoms or complications. If the tonsils are also hypertrophied, J35.1 may be more appropriate, or a combination of codes may be necessary.
Documentation should include clinical findings such as physical examination results, symptoms reported by the patient or caregivers, and any imaging studies that confirm adenoid hypertrophy. Treatment plans and outcomes should also be documented.
